Jim Cramer on Tesla and Other Stocks
Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with cult stocks, which in hindsight appear to be clear success stories.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 14,201,746 | $734,798,338 | +1% | 2.36% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 9,550,500 | $494,142,870 | -16% | 1.15% |
| 3. | 7,139,900 | $369,418,426 | +25% | 0.07% | |
| 4. | 6,918,500 | $357,963,190 | -22% | 0.06% | |
| 5. | Millennium Management Israel Englander | 5,185,435 | $268,294,407 | +248% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $54.68 | 1,830 | Officer | 62,109 | 2024-11-01 | Filing | |
| $49.78 | 2,000 | Officer | 82,672 | 2023-12-05 | Filing | |
| $48.86 | 3,071 | Officer | 79,384 | 2023-11-28 | Filing | |
| $49.81 | 8,500 | Director | 35,500 | 2023-11-20 | Filing | |
| $54.50 | 9,174 | Director | 22,109 | 2020-06-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.62 | 700 | Officer | 11,760 | 2024-11-04 | Filing | |
| $61.25 | 17,986 | Officer | 27,868 | 2023-08-24 | Filing | |
| $61.14 | 732 | Officer | 6,584 | 2023-08-03 | Filing | |
| $67.06 | 50,385 | Officer | 47,751 | 2023-05-03 | Filing | |
| $74.65 | 240,000 | Officer, Director | 236,104 | 2023-02-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 198,159,772 | $10,167,577,900 | 0.22% | |
| 2. | 168,103,766 | $8,625,404,241 | 0.21% | |
| 3. | 90,048,274 | $4,620,376,928 | 0.49% | |
| 4. | 89,446,206 | $4,589,484,830 | 0.22% | |
| 5. | 61,528,492 | $3,156,982,203 | 0.7% |
News See All
Jim Cramer Just Discussed These 13 Stocks
As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street is wondering what 2025 will hold for markets.
8 Cash-Rich Dividend Stocks To Invest In Now
Cash remains a critical asset, as companies with strong cash reserves tend to attract investors regardless of the economic climate.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
12 Best Long-Term Dividend Stocks to Invest in Right Now
The allure of steady income remains a top priority, come rain or shine in the market and for that, investors often prioritize stable companies.
10 Stocks That Are Close To Becoming Dividend Aristocrats
Income investors are drawn to Dividend Aristocrats because these stocks have consistently increased their dividends for decades.
10 Best Immunotherapy Stocks to Buy Now
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Dividend Contenders List: Top 15
Dividend stocks have long been favored by investors for the income they generate, and they become even more appealing when dividends increase over time.
10 Best Pharma Stocks To Buy Right Now
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design...
Bristol-Myers Squibb Company (NYSE:BMY) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Bristol-Myers Squibb Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Billionaire Hedge Funds
